Gonadal steroids masculinize and defeminize neuroendocrine development, including behavior. Defeminization makes males less sensitive than females to estrogen for showing female sexual behavior and cyclic gonadotropin secretion. Masculinization makes males more sensitive than females to estrogen for showing male sexual behavior. Thus masculinization and defeminization produce opposite effects on estrogen sensitivity. To study the relationship between estrogen sensitivity and estrogen binding, we studied sex differences in estrogen binding to hypothalamic cell nuclei on a regional and temporal basis. We measured the amount of estradiol (Ez) bound to cell nuclei in the preoptic area (POA), mediobasal hypothalamus (MBH), corticomedial amygdala, and cortex of gonadectomized male and female rats 30 and 60 min after [3H]E2 was injected intravenously. In the MBH, males consistently bound less Ea than females did. In the POA, males bound less En than females after 60 min, but they bound more Ez than females after 30 min. Decreased estrogen binding in the MBH may underlie defeminized sexual behavior. Similarly, decreased estrogen binding in the POA at 60 min may be a correlate of defeminized gonadotropin secretion, whereas increased estrogen binding in the POA at 30 min may be a correlate of masculinized sexual behavior. To test the hypothesis that decreased estrogen binding in the MBH and POA are correlates of defeminization, we measured Ez binding at 60 min in female rats in which masculinization and defeminization were manipulated independently. Defeminization decreased Ez binding to cell nuclei in both the POA and MBH to the level seen in males at this time point. Masculinization had no effect at this time point. The data suggest that sex differences in Ez binding to hypothalamic cell nuclei correlate reliably with sex differences in estrogen sensitivity even though masculinization and defeminization produce opposing effects on these parameters.
1972). In contrast, males are more sensitive than females to estrogen in regard to male sexual behavior. Ez is the most important neural metabolite of testosterone (T) for eliciting male sexual behavior (McEwen, 1981) and is more potent for stimulating mount and intromission patterns in males than in females (Pfaff, 1970; Pfaff and Zigmond, 1971) .
Lordosis, positive feedback, and mounting are controlled by different populations of hypothalamic neurons, but the sex differences in each of these reproductive functions develop because males are exposed to testicular androgens during a perinatal period of sexual differentiation. When androgens promote development of traits seen in males, e.g., when they increase sensitivity of mounting to ES, they are said to masculinzine development. When they suppress development of traits seen in females, e.g., when they decrease sensitivity of lordosis to Ez, they are said to defeminize development (Whalen, Vol. 3, No. 5, May 1983 1974 . The inability of males to respond to the positive feedback effect of Ez is another example of defeminization.
The bidirectional nature of sex differences in estrogen sensitivity complicates the search for their neural bases. This is particularly true when testing the hypothesis that sensitivity to estrogen depends on the ability of target neurons to bind Ea. Reported sex differences in Ez binding in the hypothalamus are unidirectional, favoring females (Whalen and Massicci, 1975; Whalen and Olsen, 1978; Olsen and Whalen, 1980) . Thus they provide no correlate for the increased sensitivity of males to ES in regard to mounting behavior. This paradox might be resolved by analyzing Ez binding separately in the mediobasal hypothalamus (MBH) and preoptic area (POA) because these hypothalamic areas are differentially involved in male and female sexual behavior.
The POA mediates hormonal effects on the development and adult expression of mounting (Christensen and Clemens, 1974; Christensen and Gorski, 1978; Davis and Barfield, 1979a; Nordeen and Yahr, 1982) . Masculinization may make mounting more sensitive to estrogen by increasing the estrogen-binding ability of POA neurons devoted to this behavior or by increasing their number. Either possibility would lead to males binding more EP than females in the pertinent POA neurons. However, the POA is also implicated in other effects of estrogen, e.g., induction of maternal behavior (Numan et al., 1977) , increased locomotor activity (Wade and Zucker, 1970) and positive feedback control of gonadotropins (Goodman, 1978; Kalra and McCann, 1975; Nance et al., 1977) . As noted above, males are less sensitive than females to estrogen in regard to positive feedback. Defeminization may eliminate positive feedback in males by decreasing the estrogen-binding ability of POA neurons subserving this function or by decreasing their number. Either possibility would lead to males binding less Ez than females in these POA neurons. Because this hypothesis predicts that the estrogen-binding properties of two POA cell groups are pushed in opposite directions during sexual differentiation, it also predicts that the resulting sex differences in binding will be difficult to detect in POA samples when the cell groups are combined. Any increase in Ez binding related to masculinization of male sexual behavior may be masked by a decrease in Ez binding related to defeminization of gonadotropin secretion. This could explain why previous attempts to detect sex differences in Ea binding in the POA have failed (Maurer and Woolley, 1974; Lieberburg and McEwen, 1977; Lieberburg et al., 1980) .
Because the POA cells that control mounting cannot be distinguished from other POA neurons, their Ez-binding properties cannot be assayed separately. However, temporal aspects of hormone binding can differ between target tissues sensitive to the same steroid (Keefer, 1981) . Thus a temporal analysis of sex differences in Ea binding to POA cell nuclei might reveal a time when neurons that control mounting dominate total binding (i.e., males would bind more Ez than females). At other times, neurons that control positive feedback or neurons that mediate estrogen-sensitive processes that are not sexually dimorphic might dominate total binding (i.e., females would bind more Ez than males, or no sex differences would appear). Our first experiment explored these possibilities, focusing on earlier time points than those previously studied. We also analyzed temporal aspects of Ez binding in the MBH. The MBH mediates hormonal effects on the development and adult expression of female sexual behavior (Christensen and Gorski, 1978; Davis and Barfield, 1979b; Davis et al., 1979; Nordeen and Yahr, 1982) . Like the POA, the MBH is implicated in other effects of estrogen, e.g., negative feedback control of gonadotropins (Bishop et al., 1972) and suppression of food intake (Wade and Zucker, 1970) , and it clearly contains a heterogeneous population of estrogen-sensitive cells (Morrell and Pfaff, 1982) . However, there is no reason to think that it contains cells that are more sensitive to estrogen in males than in females. Thus EP binding in the MBH should never favor males.
After identifying sex differences in EZ binding, we studied their relationship to behavioral differences in estrogen sensitivity. To do this, we chose a time when Ez binding in both the POA and MBH seemed to be related to defeminization. We then measured Ez binding at this time point in female rats in which masculinization and defeminization were dissociated. This is the first time that Ez binding has been studied in rats whose behavioral sensitivity to estrogen was known.
Materials and Methods
Regional and temporal analysis of estrogen binding in male and female rats
Male and female rats (Sprague-Dawley, Simonsen) matched for body weight (mean -t SEM = 185 + 5 gm for males and 188 * 4 gm for females) were gonadectomized under ether anesthesia. Five to 10 days after castration, three to eight animals 1,; each sex were injected via the jugular vein with 40 &l ol [2,4,6,7-"H(N) ]Ez (New England Nuclear, specific act? :/it:? =. 90 t,o 115 Ci/mmol) in 0.2 ml of a 25% ethanol/euiiue ,..iu,iem. Thirty or 60 min later, they were decapitated. 'l'he~x' brains were removed and kept at 4°C. Samples of POA, MBH, corticomedial amygdala (AMY), and cortex (CX) were obtained from each brain. The MBH and AMY dissections were the same as those illustrated in Luine et al. (1974) . Our POA samples differed from theirs in that we made parallel rather than oblique cuts in the parasagittal plane 1 mm on either side of the midline. Also, we used only tissue ventral to the anterior commissure. With these dissection boundaries, wet weights in milligrams of tissue samples taken from a separate set of animals (N = 6/ sex) were: male POA 14.4 + 0.5; female POA 15.8 + 1.1; male MBH 15.4 + 0.9; female MBH 16.6 f 1.2; male AMY 18.1 + 0.7; female AMY 18.9 f 1.6. An analysis of these wet weights revealed no differences between the sexes or between the POA and MBH.
Tissue samples were pooled by region and sex. Purified cell nuclei were isolated from each brain region by a modification of a method outlined by McEwen and Zigmond (1972) . Tissues were homogenized and centrifuged at 1000 X g for 10 min in NI (0.32 M sucrose, 1 mM KH2P04, 3 mM MgCl, 0.25% Triton; pH 6.5). The pellets were resuspended in NII (NI without Triton; pH 6.8) and spun again for 10 min at 1000 x g. The nuclei were then purified by centrifugation at 6900 x g for 2 hr through NIII (2.32 M sucrose, 1 mM KH2P04, 1 mM MgC1; pH 7.0). The nuclear pellets were extracted overnight in 100% ethanol. The extract was added to 10 ml of scintillation fluor (ACS, Amersham) and counted for radioactivity at approximately 35% efficiency. Data were expressed as femtomoles of Es per brain region (e.g., fmol/POA) by dividing the total femtomoles obtained by the number of animals contributing to the nuclear pellet (Kelner et al., 1980) . The experiment was repeated five times at each time point.
The DNA content of the nuclear pellets was measured by the Burton (1956) method in 6 of the 10 replications and twice when binding was not assessed. Mean values of micrograms of DNA/region were: male POA 11.85 + 1.07; female POA 11.33 + 0.70; male MBH 10.58 + 1.32; female MBH 10.99 f 1.27; male AMY 12.55 + 0.95; female AMY 13.54 + 1.03. Again, an analysis of the hypothalamic samples revealed no differences between sexes or regions.
Estrogen binding in the hypothalamus was analyzed by a 2(time) x B(sex) x 2(region) repeated measures analysis of variance according to the general procedures discussed in Winer (1971) and using a specific design provided by H. C. Kraemer for our experimental protocol. Additional 2(time) x 2(sex) analyses of variance were done for each hypothalamic region to locate the source of significant interactions. Estrogen binding in the amygdala was analyzed separately.
Relationship of estrogen binding to masculinization and defeminization To better define the relationship between Ez binding and behavioral sensitivity to estrogen, we also measured Ez binding regionally in females that were masculinized but not defeminized, females that were defeminized but not masculinized, females that were both masculinized and defeminized, and females that were neither. We used several approaches to generate these groups, including giving androgen to newborn females systemically, implanting estrogen into the hypothalami of newborn females, and capitalizing on normal variations in sexual behavior, particularly those that depend on exposure to androgen secreted in utero by the female's male sibs (Clemens et al., 1978; Meisel and Ward, 1981) .
Neonatal manipulations. Subjects were born to Sprague-Dawley (Simonsen) rats mated in our laboratory. Between 24 and 48 hr after birth, female pups from litters containing fewer males than females received one of the following treatments: bilateral implantation of cholesterol pellets into the POA; bilateral implantation of Ez pellets into the POA; or subcutaneous injection of 500 pg of testosterone propionate (TP) in 0.5 ml of safflower oil with or without bilateral implantation of cholesterol pellets in the POA. The steroid pellets were prepared and implanted as described by Christensen and Gorski (1978) except that they were only 0.75 mm tall. They contained approximately 1 pg of steroid each. At least two treatment groups were represented in each litter. Male pups were culled, and females were fostered to maintain litter sizes of six to eight.
Assessment of masculinization/defeminization. Subjects were weaned at 22 days of age and housed in pairs in wire-mesh cages. Throughout the experiment, they were maintained on a 14:10-l-n 1ight:dark cycle at 23°C with food and water freely available. When they were 65 to 80 days old, their ovaries were removed, weighed, and examined under a dissecting microscope for corpora lutea (CL). Females with fewer than two CL/ovary were considered anovulatory.
Starting 2 weeks after ovariectomy, females received daily subcutaneous injections of 2 pg of estradiol benzoate (EB) + 200 pg of dihydrotestosterone propionate (DHTP) in 0.1 ml of safflower oil for 16 days. They were tested for male sexual behavior on days 7, 12, and 16 of treatment. Starting 2 weeks later, they received 2 pg of EB/day for 12 days and were retested for male sexual behavior on days 7 and 12. For testing male sexual behavior, an experimental female was placed in a clear Plexiglas, cylindrical arena (37 to 42 cm diameter, 51 cm high) containing sawdust. After 5 min, a sexually receptive stimulus female was introduced. The number of mounts (with thrusting) and intromission patterns that occurred in the next 30 min were recorded. Midway through each test, a new stimulus female was provided unless an intromission pattern had occurred.
One week after the last test for male sexual behavior, subjects received 2 pg of EB/day for 2 days. The next day they received 500 pg of progesterone (P) and were tested for female sexual behavior 4 hr later. They then received another 3 days of EB treatment and were retested on the fourth day 4 hr after injection of P. For testing female sexual behavior, subjects were placed into an arena containing a sexually vigorous male (Long Evans). Each test ended after the subject was mounted 10 times. The number of times the subject showed lordosis when mounted was multiplied by 10 to give the lordosis quotient (LQ).
On the basis of the behavioral tests, subjects were classified in terms of both masculinization and defeminization. The defeminized females [(+)defl selected for analysis of EB binding had low LQ scores (see Figs. 4 and 6) and were anovulatory. Females that were not defeminized [(-)defl obtained high LQ scores; their ovaries were highly vascularized and contained many CL. The masculinized females [(+)masc] selected mounted frequently (see Fig. 4 and 6), whereas only two of the females that were not masculinized [ (-)masc] ever mounted a receptive partner. These classifications resulted in four distinct, nonoverlapping behavioral categories: (-)masc/(-)def; (+)masc/(-)def; (-)masc/ (+)def; (+)masc/(+)def. These categories cut across the neonatal hormone treatment groups. The (+)masc/ (+)def females received TP as neonates. Some (+)masc/ (-)def and some (-)masc/( -)def females were exposed to Ez neonatally; others received neither estrogen nor androgen. Females in the (-)masc/(+)def group were exposed to either Ez or TP neonatally.
Measurement of nuclear binding. At least 3 weeks after the last test for female sexual behavior, groups of three animals from the same behavioral category, and from the same neonatal hormone treatment group, were injected via the jugular vein with 70 PCi of [2,4,6,7-3H(N) ]Eg (New England Nuclear, 92.4 to 115 Ci/ mmol) dissolved in 0.2 ml of 25% ethanol/saline. One hour later, they were decapitated and their brains were removed and placed on ice. Purified nuclear pellets from Vol. 3, No. 5, May 1983 POA, MBH, and CX samples were obtained, and nuclear binding of Ez was assessed as described above. Data were expressed as femtomoles of EJregion.
In four determinations, (+)masc/(-)def females were compared to (+)masc/(+)def females. These data were analyzed by a B(group) x B(region) repeated measures analysis of variance. Four additional determinations compared (-)masc/(-)def females, (-)masc/(+)def females, and (+)masc/( +)def females. Data from this comparison were analyzed by a 3(group) x B(region) design.
Results
Regional and temporal analysis of estrogen binding in male and female rats. Males and females differed in nuclear Ea binding within the hypothalamus. These sex differences were both regionally and temporally specific as reflected in the significant interactions of sex x region X time (F(1,8) Nuclear binding of Ez in the POA is illustrated in Figure 2 . Here sex differences did change over time (F( 1, 8) = 10.78, p < 0.02). Thirty minutes after injection, males bound more EZ than females. Sixty minutes after injection, females bound more Ez than males. In both sexes, binding in the POA was greater than in the MBH (F(1,8) = 14.26, p < 0.01).
To confirm that sex differences in Ez binding were not due to differences in tissue dissection or nuclear yield, we converted EQ binding at 60 min after injection to femtomoles of EJmg of DNA and reassessed Ez binding in the hypothalamus. Again, females bound more Ez than males (F(l, 3) = 52.96, p < 0.01) and the POA bound more Ez than the MBH (F(l, 3) = 27.00,~ < 0.05). There was no significant sex x region interaction at this time point. As shown in Figure 3 , nuclear binding of EP in the AMY did not differ between males and females either 30 or 60 min after EP injection. Cortical accumulation of Ez was low in all determinations and did not differ between males and females at either time point.
Relationship of estrogen binding to masculinization and defeminization. In the first series of determinations, the effect of defeminization on nuclear EZ binding within the hypothalamus was assessed by comparing (+)masc/ (-)def females to (+)masc/(+)def females. Figure 4 illustrates the behavioral differences between these groups. As shown in Figure 5 , females that were both masculinized and defeminized bound less EP 60 min after injection than females that were only masculinized. This decrease is Ez binding in defeminized females only approached statistical significance (F(1,3) = 6.84, p = 0.079) when both hypothalamic regions were analyzed together.
Within the POA, Ez binding was significantly reduced (F(1,3) = 12.45, p < 0.05).
Cortical binding of Ez was low and did not differ between groups. In these determinations, we detected no difference in Ez binding between the POA and MBH. Mean body weights for (+)masc/(-)def and (+)masc/ (+)def females were 339 + 9 gm and 367 + 9 gm, respectively (t(22) = 2.97, p < 0.01).
In the second series of determinations, we compared hypothalamic nuclear Ez binding among (-)masc/(-)def females, (-)masc/(+)def females, and (+)masc/(+)def females. The behavioral differences among these groups are summarized in Figure 6 . The data on Ez binding are shown in Figure 7 . As illustrated, the three groups of females differed in nuclear Ea binding (F(2,6) = 6.01, p < 0.05). As in the previous determinations, decreased binding was associated with defeminization. The two groups of defeminized females, (-)masc/( +)def and (+)masc/(+)def, bound less Ez than the (-)masc/(-)def females (F(1,6) = 12.02, p < 0.02). This decrease was most pronounced in the MBH (F(1,6) = 16.02, p < O.Ol), but the POA showed a similar pattern (F(1,6) = 5.07, p = 0.065). Masculinization did not affect nuclear Ez binding in either hypothalamic region as assessed by comparisons between (-)masc/(+)def females and (+)masc/ (+) def females.
Cortical levels of EZ were always low and did not differ between groups. Again we detected no overall differences in nuclear EZ binding between the POA and MBH. The mean body weights for the three groups of females were: (-)masc/(-)def 356 + 13 gm; (+)masc/(+)def 390 -I 15 E;)(-)masc/(+)def 371 + 11 gm (F(2,23) = 1.74, p = . .
Discussion
Both the MBH and the POA show sex differences in estrogen binding. Such differences were observed previously for cell nuclei (Whalen and Massicci, 1975; Marrone and Feder, 1977; DeBold, 1978) or chromatin (Whalen and Olsen, 1978; Olsen and Whalen, 1980) isolated from whole hypothalamk however, this is the first time sex differences have been detected in cell nuclei isolated from individual hypothalamic regions.
Sex differences in Ez binding in the MBH consistently favor females. Because gonadal steroids defeminize female sexual behavior during development (Christensen and Gorski, 1978; Nordeen and Yahr, 1982) and activate lordosis in adults (Davis and Barfield, 1979b; Davis et al., 1979) by acting on the MBH, decreased estrogen binding in the male MBH may be related, at least in part, to defeminized sexual behavior. This possibility gains support from our observation that females that do not display lordosis show a decrease in Ez binding in the MBH comparable to the decrease seen in males. This is true when the females' sexual behavior is masculinized and when it is not. Because the behaviorally defeminized females we studied were also defeminized in terms of gonadotropin secretion, their decreased binding of Ez in the MBH could reflect this function as well: however, the MBH seems less important than the POA for mediating the positive feedback effects of estrogen (Nance et al., 1977; Goodman, 1978) . Sex differences in Ez binding in the POA can favor (Christensen and Gorski, 1978; Nordeen and Yahr, 1982) either sex depending on the time point analyzed. The and adult activation (Christensen and Clemens, 1974; POA is implicated in positive feedback control of gonad-Davis and Barfield, 1979a) of mounting behavior. As otropin secretion in adult females (Kaha and McCann, noted earlier, the sensitivities of these two reproductive 1975; Nance et al., 1977; Goodman, 1978) and in the functions to estrogen are forced in opposite directions development of anovulatory sterility after neonatal horduring sexual differentiation of males. The positive feedmone treatment (Hayashi, 1976; Nordeen and Yahr, back mechanism becomes less sensitive to estrogen. 1982). It also plays a critical role in the development Mounting behavior becomes more sensitive to estrogen. Therefore, we suggest that the sex difference in Ez binding in the POA changes direction over time because it reflects the combined estrogen-binding properties of these two cell groups, and perhaps others like them, and because these cell groups differ in the temporal aspects of their Ez binding.
By this hypothesis, decreased Ez binding in the POA of males 60 min after injection reflects, at least in part, defeminization of POA neurons mediating positive feedback. This suggestion is supported by the fact that the decrease in Ez binding at this time point in anovulatory females is comparable to the decrease seen in males; behavioral masculinization neither enhances this effect nor alters Ez binding on its own. Because the anovulatory females we studied were also defeminized behaviorally, any contribution of the POA to estrogen control of lordosis could also be reflected in the estrogen-binding properties of this region. The POA inhibits lordosis in female rats (Powers and Valenstein, 1972; Nance et al., 1977; Pfaff and Sakuma, 1979) and estrogen may stimulate lordosis, in part, by suppressing this inhibition (Pfaff, 1980) . It is not known, though, if this effect of estrogen is any different in males than in females.
Because some females received steroid-containing implants into the developing POA, it is possible that these POA implants altered the pattern of estrogen binding in this region. If the pellets per se (independent of their steroid content or neuroendocrine effects) altered Ea binding, they increased it. The groups that bound the most Ez, i.e., the females that ovulated and displayed Vol. 3, No. 5, May 1983 lordosis, were the only groups in which all females re-provide examples. Still other target cell groups must ceived steroid (cholesterol or Ez) pellets neonatally. How-underlie these functions. To activate lordosis behavior in ever, group differences in the presence of pellets did not adult female rats, only about 4% of the nuclear binding predict group differences in estrogen binding, because sites for Ez in the hypothalamus must be occupied (Davis the level of estrogen binding was nearly identical when et al., 1979) . This suggests that estrogen's effects on 3 of 12 females had a POA pellet (females that were both lordosis are mediated by a relatively small proportion of masculinized and defeminized) and when 9 of 12 females the estrogen-concentrating cells. Thus what seems to be had a POA pellet (females that were defeminized but not a moderate (15 to 20%) decrease in Ea binding after masculinized; see Fig. 7 ). On the other hand, early expo-defeminization may actually represent a dramatic reducsure to steroids may have altered estrogen binding tion in Ez binding that is limited to those neurons and/or slightly even when this was not manifested in the reprochromatin acceptor sites that are specifically related to ductive functions studied here. When females that were estrogen's effects on lordosis behavior and ovulation. One defeminized were compared to those that were not (hold-way in which gonadal hormones present perinatally could ing masculinization constant), group differences in estro-reduce or enhance Ez binding is by influencing the surgen binding were smaller when both groups received TP vivability of neurons (Arnold, 1981; Jacobson et al., 1980) . or Ez neonatally (two determinations) than they were in The death or survival of specific populations of estrogenmost determinations (five or six) in which only one group concentrating neurons could lead to regionally specific received TP or En.
sex have more labeled SDN cells in total because they have Davis, P. G., and R. J. Barfield (1979a) Activation of masculine more SDN neurons than females (Gorski et al., 1980) . sexual behavior by intracranial estradiol benzoate implants Our POA samples included both of these cell groups, but in male rats. Neuroendocrinology 28: 217-227.
we cannot specify their contribution to the sex differences Davis, P. G., and R. J. Barfield (1979b) 
